Seagen Inc (SGEN)

156.31 +2.93  +1.91% NASDAQ Jun 18, 20:00 USD
View Full Chart
Price Chart
View All SGEN News

News

View All Events

Events

Date Type Description
07/30/2021 Earnings Results Q2 2021 Earnings Results
07/30/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
04/29/2021 Earnings Results Q1 2021 Earnings Results
04/29/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/11/2021 Earnings Results Q4 2020 Earnings Results
02/11/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
07/30/2020 16:30 EST Earnings Calls Q2 2020 Earnings Call
07/30/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Seagen (formerly Seattle Genetics) is a biotech firm focused on developing antibody-drug conjugates. The company's lead product, Adcetris, has received approval for advanced front-line, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. Other approved products include Padcev (bladder cancer) and Tukysa (breast cancer). The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies.
  • URL: https://www.seagen.com
  • Investor Relations URL: https://investor.seagen.com/
  • HQ State/Province: Washington
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Jul. 30, 2021
  • Last Earnings Release: Apr. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
BBH VanEck Vectors Biotech ETF 4.11%
FBT First Trust NYSE Arca Biotech ETF 3.29%
DYN1581 Dynamic Power Global Growth Class Sr IP (USD) 2.78%
HQL Tekla Life Sciences Investors 2.65%
DYN1628 Dynamic Power American Growth Series IP (USD) 2.41%
BMEZ BlackRock Health Sciences Trust II 2.28%
IBB iShares Nasdaq Biotechnology ETF 2.21%
POAGX PRIMECAP Odyssey Aggressive Growth 2.10%
SHISX BlackRock Health Sciences Opps Svc 1.66%
HQH Tekla Healthcare Investors 1.61%
POGRX PRIMECAP Odyssey Growth 1.46%
VHCOX Vanguard Capital Opportunity Inv 1.36%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.